Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Pulmonary Fibrosis ARDS”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableStudy completedNCT02859194
What this trial is testing

The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients

Who this might be right for
Interstitial Pulmonary Fibrosis ARDSCOPD (Chronic Obstructive Pulmonary Disease)Bronchiectasis+3 more
Yonsei University 10
Not applicableLooking for participantsNCT02852928
What this trial is testing

European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank

Who this might be right for
Lung Diseases, InterstitialPulmonary Alveolar ProteinosisPulmonary Eosinophilia+3 more
Matthias Griese 1,000
Not applicableStudy completedNCT06423560
What this trial is testing

Pulmonary Fibrosis After Severe COVID-19 Pneumonia

Who this might be right for
Pulmonary FibrosisCOVID-19
IRCCS San Raffaele 61
Not applicableStudy completedNCT01271842
What this trial is testing

Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study

Who this might be right for
InfluenzaPneumonia, ViralPulmonary Fibrosis+2 more
Institut National de la Santé Et de la Recherche Médicale, France 38
Large-scale testing (Phase 3)Study completedNCT04979884
What this trial is testing

Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release SyndromePulmonary Fibrosis
Alexandria University 66
Very early researchUnknownNCT04326036
What this trial is testing

Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection

Who this might be right for
Pulmonary Alveolar ProteinosisCOPDIdiopathic Pulmonary Fibrosis+3 more
Black Tie Medical, Inc. 10
Not applicableActive Not RecruitingNCT04964115
What this trial is testing

Post Acute Sequelae of COVID-19

Who this might be right for
Covid19Sars-CoV-2 InfectionDyspnea Caused by 2019-nCoV+2 more
Vanderbilt University Medical Center 500
Not applicableActive Not RecruitingNCT04987528
What this trial is testing

Pulmonary Fibrosis During Severe COVID-19 Pneumonia

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2Acute Respiratory Distress SyndromePulmonary Fibrosis
Hôpital Européen Marseille 200
Not applicableUnknownNCT03854565
What this trial is testing

Glycocalyx Biomarkers in ARDS for Clinical Prognosis and Pulmonary Fibrosis

Who this might be right for
ARDS, HumanEndothelial DysfunctionMechanical Ventilation Pressure High
Southeast University, China 336
Large-scale testing (Phase 3)Looking for participantsNCT05075161
What this trial is testing

Pirfenidone to Prevent Fibrosis in Ards.

Who this might be right for
Acute Respiratory Distress Syndrome (ARDS)
Università Vita-Salute San Raffaele 130
Testing effectiveness (Phase 2)Study completedNCT00455767
What this trial is testing

Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients

Who this might be right for
FibrosisLung DiseaseRespiratory Disorders+4 more
Debiopharm International SA 84